A detailed history of Paradigm Financial Partners, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Paradigm Financial Partners, LLC holds 18,560 shares of NVO stock, worth $1.95 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
18,560
Previous 19,749 6.02%
Holding current value
$1.95 Million
Previous $2.82 Million 21.61%
% of portfolio
0.31%
Previous 0.43%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$119.07 - $145.42 $141,574 - $172,904
-1,189 Reduced 6.02%
18,560 $2.21 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $512,436 - $613,496
4,176 Added 26.82%
19,749 $2.82 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $1.59 Million - $2.12 Million
15,573 New
15,573 $2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Paradigm Financial Partners, LLC Portfolio

Follow Paradigm Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Financial Partners, LLC with notifications on news.